Mathematical models for the evaluation of antibiotic resistance in hospitals: A systematic review

Central European Journal of Public Health

Volumn 11, Issue 4, 2003, Pages 229-237

  Bonovas, S ^a   Panagiotakos, D B ^a,c   Charalambides, Ch ^b   Vatopoulos, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Antibiotic resistance; Mathematical models

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; EVALUATION; HOSPITAL; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PUBLIC HEALTH; REVIEW; SIMULATION;

BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; INFECTION CONTROL; MATHEMATICAL COMPUTING; MODELS, BIOLOGICAL; ORGANIZATIONAL POLICY; SUPERINFECTION;

EID: 0942286935     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Haley, R.W., Culver, D.H., White, J.W. et al.: The nationwide nosocomial infection rate. A new need for vital statistics. Am J. Epidemiol. 121, 1985, 159-67.
2. Monnet, D.L., Archibald, L.K., Phillips, L. et al: Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect. Control Hosp. Epidemiol. 19, 1998, 388-94.
3. Swartz, M.N.: Hospital-acquired infections: diseases with increasingly limited therapies. Proc. Natl. Acad. Sci. USA 91, 1994, 2420-7.
4. Arthur, M., Courvalin, P.: Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37, 1993, 1563-71.
5. Anderson, R.M., May, R.M.: Infectious Diseases of Humans. Oxford Univ Press, Oxford, 1991.
6. Murray, B.E.: Can antibiotic resistance be controlled? N. Engl. J. Med. 330, 1994, 1229-30.
7. Freeman, J., McGowan, J.E. Jr.: Risk factors for nosocomial infection. J. Infect. Dis. 138, 1978, 811-9.
8. Massad, E., Lundberg, S., Yang, H.M.: Modeling and simulating the evolution of resistance against antibiotics. Int. J. Biomed. Comput. 33, 1993, 65-81.
9. Sebille, V., Chevret, S., Valleron, A.J.: Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infect. Control Hosp. Epidemiol. 18, 1997, 84-92.
10. Sebille, V., Valleron, A.J.: A computer simulation model for the spread of nosocomial infections caused by multidrug-resistant pathogens. Comput. Biomed. Res. 30, 1997, 307-22.
11. Garber, A.M.: A discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients. Biometrics 45, 1989, 797-816.
12. Bonhoeffer, S., Lipsitch, M., Levin, B.R.: Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl. Acad. Sci. USA 94, 1997, 12106-11.
13. May, R.M., Dobson, A.P.: Presticide Resistance: Strategies and Tactics for Management. Natl. Acad. Sci. Washington DC, 1986, pp.170-193.
14. Bouma, J.E., Lenski, R.E.: Evolution of a bacteria/plasmid association. Nature. 335, 1988, 351-2.
15. Schrag, S.J., Perrot, V.: Reducing antibiotic resistance. Nature 381, 1996, 120-1.
16. Austin, D.J., Kristinsson, K.G., Anderson, R.M.: The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Nat. Acad. Sci. USA 96, 1999, 1152-6.
17. McGowan, J.E. Jr.: Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev. Infect. Dis. 5, 1983, 1033-48.
18. Moller, J.K.: Antimicrobial usage and microbial resistance in a university hospital during a seven-year period. J. Antimicrob. Chemother. 24, 1989, 983-92.
19. Gerding, D.N., Larson, T.A., Hughes, R.A., et al.: Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob. Agents Chemother. 35, 1991, 1284-90.
20. Arason, V.A., Kristinsson, K.G., Sigurdsson, J.A., et al.: Do anti-microbials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 313, 1996, 387-91.
21. Austin, D.J., Kakehashi, M., Anderson, R.M.: The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc. R. Soc. Lond. B. Biol. Sci. 264, 1997, 1629-38.
22. May, R.M., Nowak, M.A.: Superinfection, metapopulation dynamics, and the evolution of diversity. J. Theor. Biol. 170, 1994, 95-114.
23. Austin, D.J., Bonten, M.J., Weinstein, R.A., et al.: Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc. Natl. Acad. Sci. USA 96, 1999, 6908-13.
24. Lipsitch, M., Bergstrom, C.T., Levin, B.R.: The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc. Natl. Acad. Sci. USA 97, 2000, 1938-43.
25. Rao, G.G.: Risk factors for the spread of antibiotic-resistant bacteria. Drugs 55, 1998, 323-30.
26. Hawkey, P.M.: Resistant bacteria in the normal human flora. J. Antimicrob. Chemother. 18 Suppl C, 1986, 133-9.
27. Hoiby, N., Jarlov, J.O., Kemp, M., et al.: Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 349, 1997, 167-9.
28. Blower, S.M., Small, P.M., Hopewell, P.C.: Control strategies for tuberculosis epidemics: new models for old problems. Science 273, 1996, 497-500.
29. Blower, S.M., Porco, T.C., Darby, G.: Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nat. Med. 4, 1998, 673-8.
30. Freeman, J., Hutchison, G.B.: Prevalence, incidence and duration. Am. J. Epidemiol. 112, 1980, 707-23.